In line with our results, the co-overexpression of BCL-2 and β-catenin has been reported in other tumors [49] and the transcriptional regulation of BCL-2 by MITF has been documented in primary melanocytes and melanoma cells [50]. This evidence concerns the gene MITF and melanoma.